Remnant-like particle cholesterol and triglyceride levels of hypertriglyceridemic patients in the fed and fasted state

Journal of Lipid Research

Volumn 41, Issue 9, 2000, Pages 1428-1436

  Marcoux, Caroline ^a   Hopkins, Paul N ^b   Wang, Tao ^c   Leary, Elizabeth Teng ^d   Nakajima, Katsuyuki ^c   Davignon, Jean ^a   Cohn, Jeffrey S ^a  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b Cardiovascular Genetics Research Clinic   (United States)

^c OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^d Pacific Biometrics Inc   (United States)

Author keywords

Atherosclerosis; Cholesterol; Type III hyperlipoproteinemia

Indexed keywords

APOLIPOPROTEIN B; CHYLOMICRON; MONOCLONAL ANTIBODY;

ADULT; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ARTICLE; ATHEROGENESIS; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CLINICAL ARTICLE; DIET RESTRICTION; ENDOTHELIUM CELL; FEMALE; GENETIC HETEROGENEITY; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN METABOLISM; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

APOLIPOPROTEIN C-III; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CHOLESTEROL, VLDL; EATING; FASTING; HUMANS; HYPERTRIGLYCERIDEMIA; MIDDLE AGED; TRIGLYCERIDES;

EID: 0033801165     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Detection, quantification and characterization of potentially atherogenic triglyceride-rich remnant lipoproteins
2. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels
3. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma
4. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
5. Remnants of chylomicron and very low density lipoprotein impair endothelium-dependent vasorelaxation
6. Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries
7. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease
8. Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study
9. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects
10. Type III hyperlipoproteinemia (dysbeta-lipoproteinemia): The role of apolipoprotein E in normal and abnormal lipoprotein metabolism
11. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay
12. Characterization of remnant-like particles isolated by immunoaffinity gel from the plasma of type III and type IV hyperlipoproteinemic patients
13. Ratio of remnant-like particle-cholesterol to serum total triglycerides is an effective alternative to ultracentrifugal and electrophoretic methods in the diagnosis of familial type III hyperlipoproteinemia
14. Improved phenotyping of apolipoprotein E: Application to population frequency distribution
15. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
16. Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects
17. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: Comparison of the apoC-III to apoE ratio in different lipoprotein fractions
18. Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man
19. Postprandial plasma lipoprotein changes in human subjects of different ages
20. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway
21. Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil
22. Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype
23. Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons
24. Metabolism of apolipoprotein B in large triglyceride-rich very low density lipoproteins of normal and hypertriglyceridemic subjects
25. Postprandial hyperlipidemia and coronary artery disease
26. Remnant-like particles and restenosis of coronary arteries after PTCA
27. Measurement of postprandial remnant-like particles (RLPs) following a fat-loading test
28. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state
29. Postprandial lipemia: Emerging evidence for atherogenicity of remnant lipoproteins
30. Postprandial lipid metabolism
31. Relationships between the responses of triglyceride-rich lipoproteins in blood plasma containing apolipoprotein B48 and B100 to a fat-containing meal in normolipidemic humans
32. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia
33. Contribution of apoB-48 and apoB-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters